Variant NM_000492.4:c.1585-1G>A
| Name | NM_000492.4:c.1585-1G>A |
| Protein name | NP_000483.3:p.(=) |
| Genomic name (hg19) | chr7:g.117227792G>A UCSC |
| Genomic name (hg38) | chr7:g.117587738G>A UCSC |
| #Exon/intron | intron 11 |
| Legacy Name | 1717-1G>A |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | CTCTAATTTTCTATTTTTGGTAATA G GACATCTCCAAGTTTGCAGAGAAAG |
| Mutant sequence | CTCTAATTTTCTATTTTTGGTAATA A GACATCTCCAAGTTTGCAGAGAAAG |
![]() |
![]() | dbSNP rs76713772 |
![]() Not found | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | clinical data | Patient responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | no |
1 individuals carrying this variant are reported in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 100 |
|---|---|
| Asymptomatic compound heterozygote | 2 |
| CF | 79 |
| CFTR-RD | 13
|
| Fetal bowel anomalies | 3 |
| Pending (NBS) | 3 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 2904 | heterozygote | CF-causing - Trans |
| CF | 2974 | heterozygote | CF-causing - Trans |
| CF | 2975 | heterozygote | CF-causing - Trans |
| CF | 3004 | heterozygote | CF-causing - Trans |
| CF | 3008 | heterozygote | CF-causing- Undef |
| CF | 3048 | heterozygote | CF-causing - Trans |
| CF | 3144 | heterozygote | CF-causing - Trans |
| CF | 3145 | heterozygote | CF-causing - Trans |
| CF | 3149 | heterozygote | CF-causing - Trans |
| CF | 3195 | heterozygote | CF-causing- Undef |
| CF | 2903 | heterozygote | CF-causing - Trans |
| CF | 2870 | heterozygote | CF-causing - Trans |
| CF | 2561 | heterozygote | CF-causing- Undef |
| CF | 4909 | heterozygote | CF-causing - Trans |
| CF | 2621 | heterozygote | CF-causing- Undef |
| CF | 2651 | heterozygote | CF-causing- Undef |
| CF | 6505 | heterozygote | CF-causing- Undef |
| CF | 2702 | heterozygote | VUS3 - Trans |
| CF | 2703 | heterozygote | VUS3 - Trans |
| CF | 2741 | heterozygote | CF-causing - Trans |
| CF | 2862 | heterozygote | CF-causing - Trans |
| CF | 3199 | heterozygote | CF-causing - Trans |
| CF | 3294 | heterozygote | CF-causing - Trans |
| CF | 3867 | heterozygote | CF-causing- Undef |
| CF | 4046 | heterozygote | CF-causing- Undef |
| CF | 4099 | heterozygote | CF-causing- Undef |
| CF | 4117 | heterozygote | CF-causing - Trans |
| CF | 5756 | heterozygote | VUS3- Undef |
| CF | 4452 | heterozygote | CF-causing- Undef |
| CF | 4516 | heterozygote | CF-causing - Trans |
| CF | 6012 | heterozygote | varying clinical consequence- Undef |
| CF | 3854 | heterozygote | CF-causing - Trans |
| CF | 3853 | heterozygote | CF-causing - Trans |
| CF | 3851 | heterozygote | CF-causing- Undef |
| CF | 3336 | heterozygote | CF-causing - Trans |
| CF | 3337 | heterozygote | CF-causing - Trans |
| CF | 3398 | heterozygote | CF-causing- Undef |
| CF | 3460 | heterozygote | CF-causing- Undef |
| CF | 3469 | heterozygote | CF-causing- Undef |
| CF | 3678 | heterozygote | CF-causing - Trans |
| CF | 3720 | heterozygote | CF-causing - Trans |
| CF | 3797 | heterozygote | CF-causing- Undef |
| CF | 7 | heterozygote | CF-causing - Trans |
| CF | 704 | heterozygote | CF-causing - Trans |
| CF | 773 | heterozygote | CF-causing - Trans |
| CF | 936 | heterozygote | CF-causing - Trans |
| CF | 1021 | heterozygote | CF-causing - Trans |
| CF | 4775 | heterozygote | CF-causing- Undef |
| CF | 1047 | heterozygote | CF-causing - Trans |
| CF | 348 | heterozygote | CF-causing - Trans |
| CF | 17 | heterozygote | CF-causing - Trans |
| CF | 63 | heterozygote | CF-causing - Trans |
| CF | 281 | heterozygote | CF-causing - Trans |
| CF | 282 | heterozygote | varying clinical consequence- Undef |
| CF | 305 | heterozygote | CFTR-RD-causing- Undef |
| CF | 327 | heterozygote | CF-causing - Trans |
| CF | 4793 | heterozygote | CF-causing- Undef |
| CF | 1092 | heterozygote | CF-causing- Undef |
| CF | 1822 | heterozygote | CF-causing- Undef |
| CF | 1839 | heterozygote | CF-causing- Undef |
| CF | 1975 | heterozygote | CF-causing- Undef |
| CF | 2042 | heterozygote | CF-causing- Undef |
| CF | 2046 | heterozygote | CF-causing- Undef |
| CF | 2083 | heterozygote | CF-causing- Undef |
| CF | 2191 | heterozygote | CF-causing- Undef |
| CF | 2199 | heterozygote | CF-causing- Undef |
| CF | 2297 | heterozygote | CF-causing - Trans |
| CF | 5032 | heterozygote | varying clinical consequence- Undef |
| CF | 1738 | heterozygote | CF-causing- Undef |
| CF | 1713 | heterozygote | CF-causing- Undef |
| CF | 1203 | heterozygote | CF-causing - Trans |
| CF | 1231 | heterozygote | CF-causing - Trans |
| CF | 4856 | heterozygote | CF-causing- Undef |
| CF | 1557 | heterozygote | CF-causing - Trans |
| CF | 1604 | heterozygote | CF-causing- Undef |
| CF | 1622 | heterozygote | CF-causing- Undef |
| CF | 1678 | heterozygote | CF-causing- Undef |
| CF | 2362 | heterozygote | CF-causing- Undef |
| CF | 1013 | homozygote | c.1585-1G>A - p.(=) - Trans |
| Fetal bowel anomalies | 4086 | heterozygote | CF-causing- Undef |
| Fetal bowel anomalies | 4670 | heterozygote | CF-causing - Trans |
| Fetal bowel anomalies | 323 | heterozygote | CF-causing - Trans |
| CBAVD | 4928 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 3310 | heterozygote | VUS3- Undef |
| CBAVD | 3405 | heterozygote | VUS3- Undef |
| CBAVD | 551 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 986 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 5127 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 5229 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 461 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 4727 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 1330 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 1462 | heterozygote | CFTR-RD-causing- Undef |
| Asymptomatic compound heterozygote | 2863 | heterozygote | |
| Asymptomatic compound heterozygote | 4728 | heterozygote | CFTR-RD-causing - Trans |
| Bronchiectasis | 1118 | heterozygote | CF-causing - Trans |
| Pending (NBS) | 4569 | heterozygote | varying clinical consequence - Trans |
| Pending (NBS) | 6193 | heterozygote | varying clinical consequence- Undef |
| Pending (NBS) | 5291 | heterozygote | VUS3 - Trans |
| Pancreatitis | 2377 | heterozygote |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|